Open access
298
Views
7
CrossRef citations to date
0
Altmetric
Perspectives
The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy
Richard E Kast1 IIAIGC Study Center, Burlington, VT, USACorrespondence[email protected]
, Nicolas Skuli2 INSERM, Centre de Recherches en Cancérologie de Toulouse – CRCT, UMR1037 Inserm/Université Toulouse III – Paul Sabatier, Toulouse, France
, Samuel Cos3 Department of Physiology and Pharmacology, School of Medicine, University of Cantabria and Valdecilla Research Institute (IDIVAL), Santander, Spain
, Georg Karpel-Massler4 Department of Neurosurgery, Ulm University Hospital, Ulm, Germany
, Yusuke Shiozawa5 Department of Cancer Biology, Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USA
, Ran Goshen6 Eliaso Consulting Ltd., Tel Aviv-Yafo, Israel
& Marc-Eric Halatsch4 Department of Neurosurgery, Ulm University Hospital, Ulm, Germany
show all
Pages 495-514
|
Published online: 11 Jul 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.